A Rare and Complex Overlap of Toxic Epidermal Necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Case Report and Review of the Literature

Main Article Content

Carla Brenda Chávez García
Omar Alejandro Leal Avalos
Itzel Alejandra Martínez Ramírez
Laura Leticia Torres Martínez
Hortencia Yamilet Rivas Ortiz

Abstract

Toxic epidermal necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) are both life-threatening hypersensitivity reactions characterized by widespread cutaneous involvement and multiorgan damage. While these syndromes are distinct, overlapping cases are exceptionally rare and represent a diagnostic and therapeutic challenge due to their shared and divergent pathophysiological features. In this case report, we describe a 21-year-old male patient who developed overlapping TEN and DRESS following treatment with phenytoin, risperidone, and levofloxacin. The patient presented with widespread epidermal detachment, facial edema, lymphadenopathy, eosinophilia, and liver dysfunction. Clinical management required a multidisciplinary approach including prompt withdrawal of the offending drug, initiation of systemic corticosteroids and supportive care. This case highlights the critical importance of early diagnosis and tailored management in preventing severe outcomes. A review of the current literature on TEN-DRESS overlap syndrome is also provided, discussing potential immunological mechanisms, diagnostic criteria, and therapeutic strategies.

Article Details

How to Cite
Carla Brenda Chávez García, Omar Alejandro Leal Avalos, Itzel Alejandra Martínez Ramírez, Laura Leticia Torres Martínez, & Hortencia Yamilet Rivas Ortiz. (2024). A Rare and Complex Overlap of Toxic Epidermal Necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Case Report and Review of the Literature. International Journal of Medical Science and Clinical Research Studies, 4(11), 2011–2019. https://doi.org/10.47191/ijmscrs/v4-i11-25
Section
Articles

References

I. Bouvresse, S., Valeyrie-Allanore, L., Ortonne, N. et al. Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?. Orphanet J Rare Dis 7, 72 (2012). https://doi.org/10.1186/1750-1172-7-72. https://doi.org/10.1186/1750-1172-7-72.

II. Casagranda, A., Suppa, M., Dehavay, F., & del Marmol, V. (2017). Overlapping DRESS and Stevens-Johnson syndrome: Case report and review of the literature. Case Reports in Dermatology, 9(2), 1-7. https://doi.org/10.1159/000475802. https://doi.org/10.1159/000475802

III. Van Nguyen, K., Van Vu, Q., Tran, M. H., Nguyen, H. Q., Le, C. Q., Dang, B. C. T., Chu, H. C., & Van Nguyen, D. (2023). Overlapping Stevens-Johnson Syndrome and DRESS syndrome caused by Phenobarbital: A Vietnamese case report. Global Pediatric Health, 10.

https://doi.org/10.1177/2333794x231216556

IV. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071-1080.

V. Chiou C, Yang L, Hung S, et al. Clinicopathological fea- tures and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008;22(9):1044-1049.

VI. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5(1):39.

VII. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3): 609-611.

VIII. Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: com- parison with case-control analysis. Clin Pharmacol Ther. 2010;88(1):60-68.

IX. Skowron F, Bensaid B, Balme B, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): clini- copathological study of 45 cases. J Eur Acad Dermatol Venereol. 2015;29(11):2199-2205. doi:10.1111/jdv.13212 Sidoroff A,

X. Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol. 2001;28(3): 113-119.

XI. Urosevic-Maiwald M, Harr T, French LE, Dummer R. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer. Int J Dermatol. 2012;51(7):864-867.

XII. 12.-Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: com- parison with case-control analysis. Clin Pharmacol Ther. 2010;88(1):60-68.

XIII. Schwartz RA, McDonough PH, Lee BW. Toxic epi- dermal necrolysis: Part I. Introduction, history, clas- sification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013;69(2):173.e1-113. doi:10.1016/j.jaad.2013.05.003.

XIV. Cass AS, Bubrick M, Luxenberg M, Gleich P, Smith C. Renal pedicle injury in patients with multiple injuries. J Trauma. 1985;25(9):892-896.

Most read articles by the same author(s)